Also interesting
![Press release Cyanvac 1 scaled](https://www.kickstartbiomanufacturing.be/assets/uploads/site/_767x490_crop_center-center_95_none/Press-release_Cyanvac-1-scaled.jpeg)
GMP certification for Exothera further extends its viral vector manufacturing capacity
Exothera achieves GMP certification and extends its facilities by a further 2,100 m² (22,600 ft²) production bringing the total capacity to 8,600 m² (92,570 ft²) for viral vector development and manufacturing...
![650bd4b8a58539c243eb753066bd6b17 jpg](https://www.kickstartbiomanufacturing.be/assets/uploads/site/cellistics-platform-enables-faster-allogeneic-cell-therapies-manufacturing/_767x490_crop_center-center_95_none/650bd4b8a58539c243eb753066bd6b17-jpg.webp)
Cellistic's platform enables faster allogeneic cell therapies manufacturing
Cellistic's first off-the-shelf, pre-built cell line and iPSC-based manufacturing platforms enable faster and cheaper allogeneic cell therapies development.
![B759b5d2aaf39a9c1bf2914ac3e6f505 1713450782](https://www.kickstartbiomanufacturing.be/assets/uploads/site/trasis-a-world-leader-in-nuclear-medicine/_767x490_crop_center-center_95_none/b759b5d2aaf39a9c1bf2914ac3e6f505-1713450782.jpg)
Trasis, a world leader in nuclear medicine
Trasis is a Belgian company specializing in the supply of equipment and reagents for radiopharmacy that recently doubled the size of its current facilities